Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2011 by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting

Sponsor:

Collaborator:

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00365105

First received: August 16, 2006

Last updated: June 26, 2012

Last verified: February 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	March 2013 (Final data collection date for primary outcome measure)